Victory Capital Management
DMTK

Victory Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Victory Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,092,559
Closed -$6.05M – 2795
2022
Q2 		$6.05M Sell
1,092,559
-48,445
-4% -$397K 0.01% 1206
2022
Q1 		$16.8M Buy
1,141,004
+184,633
+19% +$2.47M 0.02% 951
2021
Q4 		$15.1M Buy
956,371
+103,961
+12% +$2.5M 0.01% 1009
2021
Q3 		$27.4M Buy
852,410
+112,951
+15% +$3.97M 0.03% 772
2021
Q2 		$30.7M Sell
739,459
-38,805
-5% -$1.59M 0.03% 745
2021
Q1 		$39.5M Buy
778,264
+470,571
+153% +$24.6M 0.04% 638
2020
Q4 		$9.98M Hold
307,693
– – 0.01% 1104
2020
Q3 		$3.68M Hold
307,693
– – ﹤0.01% 1262
2020
Q2 		$4.07M Sell
307,693
-77,704
-20% -$1.01M 0.01% 1211
2020
Q1 		$4.34M Buy
385,397
+77,704
+25% +$954K 0.01% 1123
2019
Q4 		$3.81M Hold
307,693
– – ﹤0.01% 1281
2019
Q3 		$1.72M Buy
+307,693
New +$3.67M ﹤0.01% 1515

Other funds holding DMTK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Victory Capital Management's DMTK Position: Q3 2022 in Review

Victory Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 1,092,559 shares — an estimated $6.05M sold.

Victory Capital Management first reported a position in DMTK in Q3 2019 and held it in 12 quarters. The position peaked at $39.5M in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • Victory Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 1,092,559 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $6.05M.
  • Victory Capital Management first reported a position in DermTech, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • Victory Capital Management's DermTech, Inc. Common Stock position peaked at $39.5M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.